Skip to main content
logo
Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
India flag India · Delayed Price · Currency is INR
750.00
-2.90 (-0.39%)
Aug 21, 2026, 3:29 PM IST

NSE:AKUMS Revenue

Akums Drugs and Pharmaceuticals had revenue of 11.67B INR in the quarter ending June 30, 2026, with 13.93% growth. This brings the company's revenue in the last twelve months to 45.04B, up 9.16% year-over-year. In the fiscal year ending March 31, 2026, Akums Drugs and Pharmaceuticals had annual revenue of 43.61B with 5.84% growth.

Revenue (ttm)
45.04B
Revenue Growth
+9.16%
P/S Ratio
2.55
Revenue / Employee
6.14M
Employees
7,337
Market Cap
114.83B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202643.61B2.40B5.84%
Mar 31, 202541.21B-607.25M-1.45%
Mar 31, 202441.82B5.24B14.34%
Mar 31, 202336.57B-180.32M-0.49%
Mar 31, 202236.75B9.49B34.81%
Mar 31, 2021 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Alembic Pharmaceuticals77.84B
Strides Pharma Science50.04B
NATCO Pharma34.85B
Eris Lifesciences32.12B
Alivus Life Sciences25.90B
Cohance Lifesciences21.42B
Aarti Pharmalabs19.69B
Sun Pharma Advanced Research Company19.09B
Revenue Rankings

Akums Drugs and Pharmaceuticals News

More News